Northwestern Medicine investigators have developed a new imaging approach to more accurately assess blood flow in the spinal ...

NervGen will meet with the FDA early next year to align on a regulatory path forward for NVG-291 in chronic spinal cord ...

Traumatic spinal cord injuries were linked to elevated risks for long-term morbidity and mortality, regardless of health prior to injury, underscoring the need for improved longitudinal care, data ...

Learn how traumatic spinal cord injury increases long-term risk of chronic illness and death - keep reading to discover more.

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial. It's a ...

Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair strategy, new research suggests. Capitalizing on the flexibility of tiny ...

Anderson Cooper: This week on 60 Minutes, we're doing a story about efforts to help people who are paralyzed with severe spinal cord injuries develop the ability to walk again. And not just walk again ...

An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom ...

About one in seven patients with spinal cord injuries use cannabis to manage their symptoms. They most commonly use street cannabis, even though medical cannabis is approved in the United Kingdom.